TY  - GEN

T1  - LB946 Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment

PY  - 2022/08/01

AU  - Simpson E

AU  - Blauvelt A

AU  - Silverberg JI

AU  - Cork M

AU  - Katoh N

AU  - Mark T

AU  - Schneider S

AU  - Wollenberg A

ED  - 

Y2  - 2024/12/22

ER  -